- Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
-
Liu CH, Chen CY, Su WW, Liu CJ, Lo CC, Huang KJ, Chen JJ, Tseng KC, Chang CY, Peng CY, Shih YL, Huang CS, Kao WY, Yang SS, Tsai MC, Wu JH, Chen PY, Su PY, Hwang JJ, Fang YJ, Lee PL, Tseng CW, Lee FJ, Lai HC, Hsieh TY, Chang CC, Chang CH, Huang YJ, Kao JH
- KMID: 2520841
- Clin Mol Hepatol.
- 2021 Oct;27(4):575-588.
- doi: 10.3350/cmh.2021.0155
Background/Aims: Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. Methods: We included 107 patients with Child-Pugh... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b
-
Son H, Sunwoo JS, Lee SK, Chu K, Lee ST
- KMID: 2516739
- J Clin Neurol.
- 2021 Jul;17(3):428-434.
- doi: 10.3988/jcn.2021.17.3.428
Background and Purpose Japanese encephalitis (JE) is caused by the JE virus of the Flaviviridae family and is spread by mosquito bites, and no specific antiviral treatment for it exists.... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
-
Jang ES, Kim KA, Kim YS, Kim IH, Lee BS, Lee YJ, Chung WJ, Jeong SH
- KMID: 2508696
- Gut Liver.
- 2020 Nov;14(6):775-782.
- doi: 10.5009/gnl19260
Background/Aims: Sofosbuvir (SOF)-based therapy has been used in Korean patients with chronic hepatitis C virus (HCV) infection since January 2016. This study aimed to in-vestigate the real-life effectiveness and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
-
Pellicelli A, Messina V, Giannelli , Distefano , Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri , Dell’Isola S, Marignani , Scifo G, Iovinella , Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito A, Barbarini
- KMID: 2500540
- Gut Liver.
- 2020 May;14(3):357-367.
- doi: 10.5009/gnl18269
Background/Aims: Patients with genotype 3 hepatitis C virus (G3-HCV) cirrhosis are very difficult to treat compared to patients with other HCV genotypes. The optimal treatment duration and drug regimen associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
-
Rashed YK, Khalaf FA, Kotb SE
- KMID: 2502863
- Clin Exp Pediatr.
- 2020 Feb;63(2):52-55.
- doi: 10.3345/kjp.2018.07150
Background: Immunomodulatory properties of interferon (IFN) have been documented. It may induce autoimmune diseases such as autoimmune thyroiditis with hypo- or hyperthyroidism. In addition, it may impair thyroid hormone synthesis... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
-
Mostafa WS, Al-Dahr MH, Omran DAH, Abdullah Z, Elmasry SH, Ibrahim MN
- KMID: 2501317
- Clin Mol Hepatol.
- 2020 Jan;26(1):60-69.
- doi: 10.3350/cmh.2019.0051
Epigenetics involved in multiple normal cellular processes. Previous research have revealed the role of hepatitis C virus infection in accelerating methylation process and affecting response to treatment in chronic hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
-
Sato S, Moriya K, Furukawa M, Saikawa S, Namisaki T, Kitade M, Kawaratani H, Kaji K, Takaya H, Shimozato , Sawada Y, Seki K, Kitagawa K, Akahane T, Mitoro A, Okura Y, Yamao J, Yoshiji H
- KMID: 2447252
- Clin Mol Hepatol.
- 2019 Mar;25(1):65-73.
- doi: 10.3350/cmh.2018.0070
BACKGROUND/AIMS: L-carnitine not only alleviates hyperammonemia and reduces muscle cramps in patients with liver cirrhosis, but also improves anemia in patients with chronic hepatitis and renal dysfunction. This study prospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease
-
Choi JH, Jeong K, Kim SM, Ko MK, You SH, Lyoo YS, Kim B, Ku JM, Park JH
- KMID: 2427027
- J Vet Sci.
- 2018 Nov;19(6):788-797.
- doi: 10.4142/jvs.2018.19.6.788
In many countries, vaccines are used for the prevention of foot-and-mouth disease (FMD). However, because there is no protection against FMD immediately after vaccination, research and development on antiviral agents... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
-
Kim YM, Kim SB, Song IH, Lee SH, Kim HS, Lee TH, Kang YW, Kim SH, Lee BS, Chae HB, Song MJ, Jang JW, Ko SY, Lee JD
- KMID: 2428759
- Clin Mol Hepatol.
- 2018 Sep;24(3):311-318.
- doi: 10.3350/cmh.2017.0070
BACKGROUND/AIMS: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
-
Yeon JE
- KMID: 2428755
- Clin Mol Hepatol.
- 2018 Sep;24(3):294-296.
- doi: 10.3350/cmh.2018.1009
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical implication of serum uric acid level in pegylated interferon and ribavirin combination therapy for chronic hepatitis C infection
-
Oh IS, Won JW, Kim HJ, Lee HW
- KMID: 2396760
- Korean J Intern Med.
- 2017 Nov;32(6):1010-1017.
- doi: 10.3904/kjim.2016.405
BACKGROUND/AIMS: Combined treatment of pegylated interferon-α (PEG-IFN) and ribavirin (RBV) has long been accepted as the standard treatment for chronic hepatitis C virus (HCV) infection. Many predictive factors for treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data
-
Ki M, Choi HY, Kim KA, Jang ES, Jeong SH
- KMID: 2395389
- Gut Liver.
- 2017 Nov;11(6):835-842.
- doi: 10.5009/gnl17034
BACKGROUND/AIMS: The introduction of direct-acting antivirals (DAA) in 2013 revolutionized hepatitis C virus (HCV) treatment, offering a cure rate >90%. However, this therapy is expensive, and estimations of the number... -
- CITED
-
- Close
- SHARE
-
- Close
- Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus
-
Tamai H, Ida Y, Kawashima , Shingaki N, Shimizu R, Moribata K, Nasu T, Maekita T, Iguchi M, Kato J, Nakao T, Kitano M
- KMID: 2412236
- Gut Liver.
- 2017 Jul;11(4):551-558.
- doi: 10.5009/gnl16525
BACKGROUND/AIMS: The present study aimed to evaluate the safety and efficacy of simeprevir-based triple therapy with reduced doses of pegylated interferon (PEG-IFN) and ribavirin for interferon (IFN) ineligible patients, such... -
- CITED
-
- Close
- SHARE
-
- Close
- Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
-
Jang ES, Kim YS, Kim KA, Lee YJ, Chung WJ, Kim IH, Lee BS, Jeong SH
- KMID: 2412235
- Gut Liver.
- 2017 Jul;11(4):543-550.
- doi: 10.5009/gnl16530
BACKGROUND/AIMS: To evaluate the era of direct acting antivirals (DAAs), we must understand the treatment patterns and outcomes of interferon-based therapy for hepatitis C virus (HCV) infection. We aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus
-
Lee MJ, Kim KH, Yi J, Choi SJ, Choe PG, Park WB, Kim NJ, Oh MD
- KMID: 2387719
- Korean J Intern Med.
- 2017 Jul;32(4):731-737.
- doi: 10.3904/kjim.2016.109
BACKGROUND/AIMS: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by severe fever with thrombocytopenia syndrome virus (SFTSV), a novel bunyavirus. As yet, there is no effective... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
-
Shin SR, Kim YS, Lim YS, Lee JS, Lee JW, Kim SM, Jeong SH, Sohn JH, Lee MS, Park SH
- KMID: 2412194
- Gut Liver.
- 2017 Mar;11(2):270-275.
- doi: 10.5009/gnl16163
BACKGROUND/AIMS: Because of the limited geographic distribution, there have been insufficient data regarding hepatitis C virus (HCV) genotype 6 in Korea. This study aimed to investigate the clinical characteristics and... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Treatment Cases of Severe Fever and Thrombocytopenia Syndrome with Oral Ribavirin and Plasma Exchange
-
Park I, Kim HI, Kwon KT
- KMID: 2375103
- Infect Chemother.
- 2017 Mar;49(1):72-77.
- doi: 10.3947/ic.2017.49.1.72
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease. The primary symptoms associated with SFTS are fever, thrombocytopenia, leukopenia, nausea, and vomiting. Disease progression shows high mortality rate... -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcoidal Reaction on Old Scars during Pegylated Interferon-α and Ribavirin Therapy in a Patient with Chronic Hepatitis C
-
Kim SH, Lee KS, Oh BH, Kim SA
- KMID: 2371095
- Korean J Dermatol.
- 2017 Feb;55(2):149-151.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation
-
Seok MG, Lee TH, Yun SR, Hwang WM, Yoon SH, Choe IS, Kang SJ, Hong JY, Kim DS
- KMID: 2366130
- Yeungnam Univ J Med.
- 2016 Dec;33(2):150-154.
- doi: 10.12701/yujm.2016.33.2.150
Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
-
Lee SJ, Cho YK, Na SY, Choi EK, Boo SJ, Jeong SU, Song HJ, Kim HU, Kim BS, Song BC
- KMID: 2373140
- Clin Mol Hepatol.
- 2016 Sep;22(3):390-395.
- doi: 10.3350/cmh.2015.0050
Some recent studies have found regression of liver cirrhosis after antiviral therapy in patients with hepatitis C virus (HCV)-related liver cirrhosis, but there have been no reports of complete regression... -
- CITED
-
- Close
- SHARE
-
- Close
